OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021
Molly Steele, Alexia Couture, Carrie Reed, et al.
JAMA Network Open (2022) Vol. 5, Iss. 7, pp. e2220385-e2220385
Open Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status — United States, April 2021–September 2022
Jefferson M. Jones, Irene Molina Manrique, Mars Stone, et al.
MMWR Morbidity and Mortality Weekly Report (2023) Vol. 72, Iss. 22, pp. 601-605
Open Access | Times Cited: 96

Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods
Ruth Link‐Gelles, Matthew E. Levy, Karthik Natarajan, et al.
JAMA Network Open (2023) Vol. 6, Iss. 3, pp. e232598-e232598
Open Access | Times Cited: 67

mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States
Hung Fu Tseng, Bradley K. Ackerson, Lina S. Sy, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44

Megastudy shows that reminders boost vaccination but adding free rides does not
Katherine L. Milkman, Sean F. Ellis, Dena M. Gromet, et al.
Nature (2024) Vol. 631, Iss. 8019, pp. 179-188
Open Access | Times Cited: 14

mRNA Vaccine Nanoplatforms and Innate Immunity
Lai Wei, Chunhong Dong, Wandi Zhu, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 120-120
Open Access | Times Cited: 11

COVID-19 and Influenza Vaccine Coadministration Among Older U.S. Adults
Daniel A. Harris, Preeti Chachlani, Kaleen N. Hayes, et al.
American Journal of Preventive Medicine (2024) Vol. 67, Iss. 1, pp. 67-78
Open Access | Times Cited: 10

Epidemiology and Clinical Presentation of COVID-19 in Older Adults
Yasin Abul, Ciera Leeder, Stefan Gravenstein
Infectious Disease Clinics of North America (2022) Vol. 37, Iss. 1, pp. 1-26
Open Access | Times Cited: 31

Covid-19 Vaccine Hesitancy and Under-Vaccination among Marginalized Populations in the United States and Canada: A Scoping Review
Peter A. Newman, Duy A Dinh, Thabani Nyoni, et al.
Journal of Racial and Ethnic Health Disparities (2023)
Open Access | Times Cited: 19

Evaluating the COVID-19 vaccination program in Japan, 2021 using the counterfactual reproduction number
Taishi Kayano, Yura Ko, Kanako Otani, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18

Genetic Analysis of Obstructive Sleep Apnea and Its Relationship with Severe COVID-19
Satu Strausz, Е.А. Агафонова, Varvara Tiullinen, et al.
Annals of the American Thoracic Society (2024) Vol. 21, Iss. 6, pp. 961-970
Open Access | Times Cited: 5

A potential association between COVID-19 vaccination and development of Alzheimer’s disease
Jee Hoon Roh, Inha Jung, Yunsun Suh, et al.
QJM (2024) Vol. 117, Iss. 10, pp. 709-716
Closed Access | Times Cited: 5

Optimizing Missouri's Preparation for the Next Pandemic: Lessons Learned from COVID-19: Part 2.
David S. McKinsey, Joel P. McKinsey, Julie R McKinsey, et al.
PubMed (2025) Vol. 122, Iss. 1, pp. 12-18
Closed Access

COVID-19 clinical presentation, management, and epidemiology: a concise compendium
David P. Maison, Hawi Tasissa, Amelia N. Deitchman, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access

Can Operation Warp Speed Serve as a Model for Accelerating Innovations beyond COVID Vaccines?
Arielle D’Souza, Kendall Hoyt, Christopher M. Snyder, et al.
Entrepreneurship and Innovation Policy and the Economy (2025) Vol. 4, pp. 103-138
Closed Access

COVID-19 Vaccination and Odds of Post–COVID-19 Condition Symptoms in Children Aged 5 to 17 Years
Anna R. Yousaf, Josephine Mak, Lisa Gwynn, et al.
JAMA Network Open (2025) Vol. 8, Iss. 2, pp. e2459672-e2459672
Open Access

Age-associated differences in mucosal and systemic host responses to SARS-CoV-2 infection
Jillian H. Hurst, Aditya Mohan, Trisha Dalapati, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

COVID-19 Biopharmaceutical Innovation and Industry Appropriation
Tomas Philipson, A. Mark Fendrick, Aarushi Kataria, et al.
Forum for Health Economics & Policy (2025)
Closed Access

Long-term Protection Associated With COVID-19 Vaccination and Prior Infection
Mark W. Tenforde, Ruth Link‐Gelles, Manish M. Patel
JAMA (2022) Vol. 328, Iss. 14, pp. 1402-1402
Open Access | Times Cited: 24

Return on Investment of the COVID-19 Vaccination Campaign in New York City
Pratha Sah, Thomas N. Vilches, Seyed M. Moghadas, et al.
JAMA Network Open (2022) Vol. 5, Iss. 11, pp. e2243127-e2243127
Open Access | Times Cited: 23

Characterization of BNT162b2 mRNA to Evaluate Risk of Off-Target Antigen Translation
Himakshi Patel, Kun Zhang, Rachael Utegg, et al.
Journal of Pharmaceutical Sciences (2023) Vol. 112, Iss. 5, pp. 1364-1371
Open Access | Times Cited: 14

Page 1 - Next Page

Scroll to top